JoseTZaglulMD

Psychiatry • Bradenton, FL

Child & Adolescent Psychiatry, Psychopharmacology

Psychiatry Residency Program Director, Centerstone, Florida

Join to view full profile

Dr. Zaglul is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Zaglul's full profile

Already have an account?

Office
379 6th Avenue West
Bradenton, FL 34205
Phone+1 941-782-4100

Fax+1 941-782-4103
Is this information wrong?

Education & Training

University of South Florida MorsaniFellowship, Child and Adolescent Psychiatry, 1993 - 1995
University of South Florida MorsaniResidency, Psychiatry, 1989 - 1993
Universidad Autonoma de Santo DomingoClass of 1986

Certifications & Licensure

FL State Medical License 1991 - 2026
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Child & Adolescent Psychiatry

Clinical Trials

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex Start of enrollment: 2011 Jun 01
Completed
Phase 3
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia Start of enrollment: 2011 Jul 01
Completed
Phase 3
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia Start of enrollment: 2011 Sep 01
Completed
Phase 3
PEARL Schizophrenia Maintenance Start of enrollment: 2011 Sep 01
Completed
Phase 3
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 Start of enrollment: 2012 Jun 01
Completed
Phase 3
Pediatric Schizophrenia Efficacy and Safety Study Start of enrollment: 2013 Aug 01
Completed
Phase 3
Lurasidone Pediatric Autism Study Start of enrollment: 2013 Aug 01
Completed
Phase 3
Pediatric Open-Label Extension Study Start of enrollment: 2013 Sep 30
Completed
Phase 3
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients Start of enrollment: 2014 Apr 01
Completed
Phase 3
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD Start of enrollment: 2016 Jan 01
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Rethinking Psychiatry Residency Training as Community Program Directors.
Maria P Chona San Gabriel, Rebecca S Lundquist, Omair Abbasi, Narpinder Kaur Malhi, Salma Malik, Jose Zaglul> ;Academic Psychiatry. 2024 Mar 19
Presymptomatic testing for Huntington's disease. Emotional aspects.
Zak, J. P., Zaglul, J. T., Mueller, O. T., Diamond, T.> ;J Fla Med Assoc. 1994 Feb